Purpose Information regarding the use of lung ultrasound (LUS) in patients with Coronavirus
disease 2019 (COVID-19) is quickly accumulating, but its use for risk stratification and …

Importance In the last decade, immune checkpoint inhibitors (ICIs) have been approved for
the treatment of many cancer types. Immune checkpoint inhibitor–associated myocarditis has …

Background A large number of patients around the world are recovering from coronavirus
disease 2019 (COVID-19); many of them report persistence of symptoms. The aim of this study …

Background: Serum lactate dehydrogenase (LDH) is elevated in various diseases. objectives:
To analyze serum LDH as a distinguishing clinical biomarker and as a predictor of in-…

Background Neutrophil/lymphocyte ratio (NLR) is a novel biomarker that can single out
individuals at risk for vascular events. We assessed whether NLR provides additive prognostic …

Aims We aim to assess changes in routine echocardiographic and longitudinal strain parameters
in patients recovering from Coronavirus disease 2019 during hospitalization and at 3-…

Background The scope of pericardial involvement in COVID‐19 infection is unknown. We
aimed to evaluate the prevalence, associates, and clinical impact of pericardial involvement in …

OBJECTIVES: High values of Red Blood Cell Distribution Width (RDW) have been associated
with adverse outcome in various clinical settings. The mechanism behind this association …

A recent study shows that left ventricular ejection fraction (LVEF) is preserved in most patients
with coronavirus disease-2019 (COVID-19) infection, but LV diastolic and right ventricular (…

Background Small scale cohorts demonstrated an association between body mass index (BMI)
and diastolic function in a metabolically healthy population. We aimed to characterize the …